Copyright © 2002 by the European Society of Cardiology.
Editorials
First-line treatment for hypertension
Clinical Pharmacology and Therapeutics, Royal Hallamshire Hospital, Sheffield, U.K.
References
- Ramsay LE, Wallis EJ, Yeo WW, Jackson PR. The rationale for differing national recommendations for the treatment of hypertension. Am J Hypertens. 1998;11:79S88S[CrossRef][ISI][Medline]
- Arch Intern Med. 1997;157:24132446[Abstract]
- Ramsay LE, Williams B, Johnston GD,. British Hypertension Society guidelines for hypertension management: summary. BMJ. 1999;319:630635
[Free Full Text] - Chalmers J, MacMahon S, Mancia G,. 1999 World Health OrganizationInternational Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999;21:10091060[ISI][Medline]
- Lancet. 2000;356:19551964[CrossRef][ISI][Medline]
- Pahor M, Psaty BM, Alderman MH,. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet. 2000;356:19491954[CrossRef][ISI][Medline]
- Rafflenbeul W. Prognostic benefits of antihypertensive therapy: concern about another solid meta-analysis. Br J Cardiol. 2000;7:703708
- Avanzini F, Tognoni G. INSIGHT and NORDIL. Lancet. 2000;356:19271928[Medline]
- Neaton JD, Grimm RH Jr, Prineas RJ. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993;270:713724[Abstract]
- Materson BJ, Reda DJ, Cushman WC,. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328:914921
[Abstract/Free Full Text] - N Engl J Med. 2000;342:145153
[Abstract/Free Full Text] - Psaty BM, Heckbert SR, Koepsell TD,. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620625[Abstract]
- Psaty BM, Smith NL, Siscovick DS,. Health outcomes associated with Antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277:739745[Abstract]
- JAMA. 2000;283:19671975
[Abstract/Free Full Text] - Ramsay LE, Ul Haq I, Yeo WW, Jackson PR. Interpretation of prospective trials in hypertension: do treatment guidelines accurately reflect current evidence? J Hypertens. 1996;14:S187S194
- Wallis EJ, Ramsay LE, Ul Haq I, Ghahramani P, Jackson PR. Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation. J Hypertens. 2001;19:691696[CrossRef][ISI][Medline]
- Hansson L, Zanchetti A, George Carruthers S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:17551762[CrossRef][ISI][Medline]
- BMJ. 1998;317:713720
[Abstract/Free Full Text] - Collins R, Peto R. Antihypertensive drug therapy: effects on stroke and coronary heart disease. Swales JD. Textbook of hypertension. Oxford: Blackwell Scientific; 1992. p. 11561164
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||